adapting pharmacological dosefinding designs early phase behavioral intervention development research elizabeth kuhl towner april idalski carcone samiran ghosh steven ondersma wayne state university school medicinemario stylianou national institutes health national heart lung blood institute bethesda maryland systematic dosefinding designs develop behavioral health interventions lacking contrast drug development research consistently follows prescribed regulated iterative pathway begins empirically establishing optimal drug dose adapting dosefinding methodologies drug development literature offers several advantages increasing feasibility efficiency rigor important intervention refining step behavioral intervention development article discusses current state science dose finding within behavioral intervention development literature detailed overview drug development dosefinding methodology accelerated biased coin upanddown design presented using work adapt prevention plus intervention treatment pediatric obesity mhealth delivery example design applied empirically derive dose behavioral intervention keywords intervention development dose finding supplemental materials  empirically deriving dose important rarely completed step maximizing effectiveness behavioral health interven tions implementation dissemination potential models translational research like national institutes health orbit model specify dosefinding studies included part early phase behavioral intervention development ensure components interventions jected efficacy testing optimized czajkowski  absence refining step potentially efficacious intervention categorized ineffective abandoned fact slightly higher dose differentresults kalichman  alternatively efficacious interven tion implemented realworld settings deemed expensive perhaps smaller dose would achieved health outcome finally suboptimal dosing also result high rates attrition therapist burnout kalich  voils   instead conducting empirical investigations behavioral inter vention dosing typically derived precedent anecdotal evidence clinical experience andor asking targeted popula tion dosing preferences kalichman  voils   approaches significant limitations insuf ficient attention dose substantial negative effects tempts evaluate literature given area systematic reviews often include small fraction extant intervention trials dosing information reported kalichman  example systematic  metaregression behav ioral prevention intervention programs pediatric obesity heerman colleagues  excluded identified rcts publications include sufficient information determine dose metaregression included tended dose majority trials reviewed report actual received dose dose derived anecdotal evidence limited generalizability population provider setting specific finally asking targeted population dosing preferences important developing humancentered interven tions individual responses consistent optimal  efficacy costeffective another challenge empirically establishing dose behavioral interventions absence systematic efficient dosefinding methodologies instead tiple iterative randomized controlled trials rcts often necessary design power limitations restrict numx elizabeth kuhl towner april idalski carcone samiran ghosh department family medicine public health sciences wayne state university school medicine steven ondersma merrill palmer skillman institute department psychiatry behavioral neurosciences wayne state university school medicine mario stylianou national institutes health national heart lung blood institute bethesda maryland steven ondersma department obstetrics gynecology reproductive biology division public health michigan state university work supported award elizabeth kuhl towner april idalski carcone grants boost program office vice president research wayne state university correspondence concerning article addressed elizabeth kuhl towner department family medicine public health sciences division behavioral sciences wayne state university school icine  woodward avenue h detroit  email ekuhlmedwayneeduthis document copyrighted    allied publishers article intended solely personal individual user disseminated broadly health psychology         this article published online first november  dosing levels evaluated within single study voils  increases already lengthy timeline intervention development effectiveness implementa tion trials contrast traditional drug development follows scribed regulated iterative pathway efficacy trials phase occur recommended drug dose empirically identified phase impact desired health outcome empirically established phase voils   phase studies identify either maximally tolerated dose largest dose drug administered minimizes toxicity rate medication small predetermined proportion targeted population chemotherapy yielding negative adverse health comes population minimally effective dose smallest dose medication yields desired health outcome large prespecified portion targeted population pain medication viding pain relief population pace stylianou  testing completed application established efficient dosefinding methodologies characteristics designs address many challenges faced behavioral scientists could thus improve rigor early phase behavioral intervention research many pharmaceutical dosefinding designs article focuses accelerated biased coin upand design abcd stylianou follmann  abcd frequentist method type upand dosefinding design aims achieve balance tolerability fined toxicity nonresponse failure dose response defined desired outcome interest success assumption monotonic relationship drug inten sity toxicity participants allocated higher lower drug dose based upon treatment outcome previous participant intervention dose thus identified systematic empirical fashion abcd based upon biased coin upand method better operating characteris tics upanddown designs pace stylianou  stylianou flournoy  stylianou proschan flournoy  abcds primary modification biased coin method abcd allows multiple participants enrolled given time whereas permits participant time advantages abcd behavioral intervention development simplicity implement pared dosefinding designs continual reassess ment method voils   adaptive proach includes randomization fact requires relatively small sample  ability evaluate multiple dosing levels study adapting abcd behavioral intervention development research sections follow describe abcd methodology ongoing work adapt stage pediatric obesity treatment prevention plus intervention mhealth delivery illustrate method could applied empir ically derive dose behavioral health interventionadapting stage pediatric obesity treatment mhealth delivery expert committee prevention assessment treat ment child adolescent overweight obesity recom mends stepped approach treating pediatric obesity barlow  stage intervention intended delivery every child meets criteria overweight obesity every provider pediatricians nurse practitioners high scal ability wide reach achieving small significant changes many children possible aims populationlevel inter ventions delivering recommended providers motivational interviewing miller rollnick  collaboratively goals families modify behav iors increase preschoolers obesity risk increase fruit vegetable intake decrease screen intervention stepped stage structured weight management proved status evident months multiple barriers implementation documented chief among lack training providers pediatric weight management insufficient time integrate already brief wellchild visits piche clarson callaghan harris  perrin flower garrett ammerman  spivack swietlik alessandrini faith  currently developing mhealth prevention plus tervention preschoolers mppip technology delivered components brief motivational sessions sepa rated month automated mitailored text messages text messaging common type mhealth inter vention component obesity treatment literature siopis chey allmanfarinelli  thomas bond  study empirically evaluated dose frequency leads effective weight control contrast many published mhealth interventions obesity textmessage component mppip intervention exchanges twoway textmessaging thus ideal candidate dosefinding study focus dimension dose frequency researchers might also select designs evaluate duration total length intervention amount length interven tion contact voils  selecting versus important first step applying abcd determine whether design focus identifying seem intuitive selection behavioral intervention development research design aims identify smallest dose achieves particular health outcome response apply abcd identify first necessary define means behavioral intervention toxic strict translation drug development cannot made behavioral interventions yield physiological toxicity medication might voils  however adverse nega tive outcomes could occur dose behavioral inter vention high include psychosocial toxicity therapist burnout patient dependency kalichman  excessive costs associated treatment delivery attrition applied example abcd focus identifying text messages administeredthis document copyrighted    allied publishers article intended solely personal individual user disseminated broadly towner month define toxicity attrition choice instead study dose gested moderator pediatric weight outcomes janicke  attrition pediatric obesity interventions high dhaliwal  benefits text messaging opportunity realtime intervention insufficient evidence behavioral intervention develop ment literature conclude frequency text messaging particularly twoway messaging individuals tolerate becomes overly burdensome given choice study subsequent sections describe design proce dures  type abcd design readers referred stylianou follmann  details designing abcd study identify determining dosing levels noted abcd evaluates multiple dosing levels study extent possible dosing levels derived combination strategies commonly used behav ioral intervention development literature systematic  literature identifying preferences targeted population andor anecdotal clinical experience efforts searchers need decide hypothesized target dose studies identify targeted dose dose produce toxicity undesired outcome small predetermined percentage population maximum number doses included design researchers encouraged include minimum doses hypothesized target dose ning  mppip reviewed obesity treatment outcome liter ature considered text message dose within intervention using motivational interviewing technology platform mppip yielded improvements motivation controller medi cation lung functioning kolmodin macdonell naar gibsonscipio secord  macdonell gibsonscipio naarking chen  formative work caregivers young children exceeded recommenda tion sugarsweetened beverages  adult pediatric obesity treatment outcome literatures revealed wide range text messaging doses ranging week four times militello melnyk hekler small jacobson  nezami ward lytle ennett tate  price  siopis  intervention using technology platform include text messaging  young adults highly satisfied receiving messages daily days motivational sessions treatment package overall yielded improvements motivation medication adher ence lung functioning kolmodin macdonell  macdonell  finally formative work revealed caregivers targeted population also preferred daily text messaging example identified daily textmessaging target dose abcd evaluate seven dose frequency levels weekly twice weekly every daily twice three times four times daydefining h prior initiating dosefinding study researchers must fineh study targeted toxicity level proportion targeted population expected experience icity study hmust h stylianou follmann  example mppip want identify text messaging month results minimal intervention attrition thus hh determining sample size extensive simulations considering large variety dose response curves conducted development abcd design simulations concluded sample size  adequate obtain estimate target dose within dose level true dose stylianou  additional information sample size considerations  appendix online supplemental materials stylianou follmann  formal rules determining number range appropriate rather factors length intervention tested timeline project budget stronger impact sample size decisions dosing procedures abcd uses twostep approach promote faster arrival figure step begins first participant allocated hypothesized target dose dose expected yield toxicity participant nontoxic response step continues next participant allocated next highest dose pattern participant active intervention time subsequent participant allocated next higher dose repeats participant meets criteria toxicity time study moves step figure presents hypothetical example dosing flow first seven families participate dosefinding study step first family family allocated hypothesized target dose daily text messaging meets criterion nontoxic response retention family replied messages allocated dose since family expe rience toxicity study remains step family allocated next highest dose text messages twice daily family respond text message considered toxic response study moves step abcd methodology first participant step allo cated next lower dose dose yielded toxic response step dosing procedures depend upon three factors ahor desired target toxicity level intervention dose response previous participant biased coin flip based upon predefined probability success stylianou follmann  noted figure previous participant meets criterion toxicity next participant allo cated next lower dose previous participant meets criterion nontoxicity next participant randomized based upon probability bhhhhto next higher dose probability hbto dose step response counted complete either participant reaches evaluation period length intervention soonthis document copyrighted    allied publishers article intended solely personal individual user disseminated broadly dosefinding designs behavioral intervention criterion toxicity dose allocation newly enrolled participants usually based upon last participant enroll study efforts minimize bias might occur burst recruitment ensure sample exhausted dose abcd also limits number participants enrolled particular dose time three stylianou follmann  continuing applied example figure step begins allocating next family family dose daily text messaging dose next lower dose achieved toxicity step family begins since family criterion toxicity nontoxicity also allocated dose daily text messaging family begins since neither family family criterion toxicity also allocated dose daily text messaging family arrives three families dose daily text messaging already must wait start family families currently amid intervention meets criterion toxicity attrition nontoxicity retention occurs family dfails respond text message thus meets criterion toxicity attrition family begins intervention next family toxic response attrition allocated next lower dose every text messaging family enrolls last family complete family nontoxic response allocated probability ofbh h next higher dose  h dose example outcome domization family receives dose daily text messaging study would continue manner desired sample size nh achieved stopping rules target dose within levels tested participants keep allocated lowest dose target dose actually lower minimum dose included design highest dose target dose actually higher maximum dose included design allocation minimum maximum dose occurs three four figure dosing procedures twostep biasedcoin design dosefinding study identify maximally tolerated dose hmaximally tolerated dose hhypothesized target dose hdose yielding toxic response step bhbetahhthe desired toxicity level intervention percent expected toxic response hrandomization figure dosing pattern hypothetical abcd determine text messaging abcd haccelerated biasedcoin upanddown design hminimally effective dose htoxic response attrition allocated dose hnontoxic response retention allocated dosethis document copyrighted    allied publishers article intended solely personal individual user disseminated broadly towner consecutive participants reasonable stop study reassess specified dose range initiate study different dosing range informed previous study determining estimation recommended dose determined assuming probability toxicity increases increasing dose isotonic regression using pooled adjacent violators algorithm pava robertson wright dykstra  natural estimate probability toxicity dose level tested isotonic estimates probability toxicity used produce estimator target dose code available produce estimates along confidence intervals contact  conclusions despite importance treatment optimization improving translational process czajkowski  early phase work develop behavioral interventions include studies empirically determine dose identification systematic efficient dosefinding designs help address methodologies drug development abcd adapted behavioral researchers provide several advantages increasing feasibility rigor dose finding early phase intervention development research including many adaptive include randomization require range doses tested designs also implemented small samples compromising power making ideal grant mechanisms specific early phase research often shorter timelines smaller budgets intervention development consideration must given variables impact dosing examples include sociodemographic characteristics time since diagnosis disease severity neurocognitive emotional states content also context intervention includes text messaging like exam presented article variables might addressed work informs dosefinding design others later point developmental trajectory sample sizes larger sufficient power explore mediation moderation drug development dosefinding methodologies suit able behavioral interventions however example fining response study aims identify minimally effective dose behavioral intervention intuitive majority behavioral interventions target specific behaviors health outcomes weight loss adherence however defin ingtoxicity difficult kalichman  suggests term psychosocial toxicity describe unintended outcomes behav ioral interventions like therapist dependency exhausting tions additional toxic outcomes might include attrition ther apist burnout whether explore toxicity behavioral interventions warrants additional thought exploration another consideration drug development dosefinding designs intended evaluate interventions treatments delivered individual level appropriate behavioral interventions delivered group level summary empirically deriving dose imperative optimiz behavioral health interventions however systematic designsfor completing step behavioral literature lacking drug development literature offers several designs adapted behavioral intervention development address critical references barlow  expert committee recommendations regarding prevention assessment treatment child adolescent weight obesity summary report pediatrics suppl s s  czajkowski powell adler naarking reynolds hunter charlson  ideas efficacy orbit model developing behavioral treatments chronic diseases health psychology   hea dhaliwal nosworthy holt zwaigenbaum avis rasquinha ball  attrition management pediatric obesity integrative  childhood obesity  piche clarson callaghan harris  childhood overweight obesity management national perspective primary health care providers views practices perceived barriers needs paediatrics child health   pch heerman jaka berge trapl sommer samuels barkin  dose behavioral interventions prevent treat childhood obesity systematic view metaregression international  behavioral nutrition physical activity article  s janicke steele gayes clifford schneider westen  systematic  meta analysis comprehensive behavioral family lifestyle interventions dressing pediatric obesity  pediatric psychology  kalichman  enough enough absence dosedetermination trials impedes implementation behavioral interventions aids behavior   s kolmodin macdonell naar gibsonscipio secord  detroit young adult asthma project pilot technologybased medication adherence intervention african  emerging adults  adolescent health   ning  upanddown designs phase clinical trials contemporary clinical trials   orgjcct macdonell gibsonscipio naarking chen  text messaging measure asthma medication symp toms urban african  emerging adults feasibility study  asthma    militello melnyk hekler small jacobson  automated behavioral text messaging facetoface interven tion parents overweight obese preschool children results pilot study jmir mhealth uhealth  mhealth miller rollnick  motivational interviewing helping people change york guilford press nezami ward lytle ennett tate  mhealth randomized controlled trial reduce sugar sweetened beverage intake preschoolaged children pediatric sity   document copyrighted    allied publishers article intended solely personal individual user disseminated broadly dosefinding designs behavioral intervention pace stylianou  advances limitations upanddown methodology precis clinical study design dose estimation anesthesia research anesthesiology   perrin flower garrett ammerman  preventing treating obesity pediatricians selfefficacy barriers resources advocacy ambulatory pediatrics   doiorgar price ferisin sharifi steinberg bennett wolin taveras  development implementation interactive text messaging campaign support behavior change childhood obesity randomized controlled trial  health munication    robertson wright dykstra  order restricted statistical influence york wiley siopis chey allmanfarinelli  systematic  metaanalysis interventions weight management using text messaging  human nutrition dietetics suppl  spivack swietlik alessandrini faith  primary care providers knowledge practices perceived barriers treatment prevention childhood obesity obesity    flournoy  dose finding using biased coin upanddown design isotonic regression biometrics   stylianou follmann  accelerated biased coin upanddown design phase trials  biopharmaceutical statistics   stylianou proschan flournoy  estimating probability toxicity target dose following upanddown design statistics medicine   sim thomas bond   innovations digital health technology promote weight control current diabetes reports article  voils chang crandell leeman sandelowski maciejewski  informing dosing interventions randomized trials contemporary clinical trials  http dxdoiorgjcct voils king maciejewski allen yancy shaffer  approaches informing optimal dose behavioral interventions annals behavioral medicine   received october  revision received  accepted june  hthis document copyrighted    allied publishers article intended solely personal individual user disseminated broadlytowner